The Arcady Group

Turning the science of patient medication adherence into action

  • Who we are
    • About Our Company
    • About Our Founder
    • Our Core Team
    • Partner Organizations
    • Photo Gallery
  • Our Work
  • Global Access
    • Resources
    • Insights
  • Contact Us
  • LinkedIn

August 2, 2018

Publication: Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China – study protocol for a cluster randomised controlled trial

Over the past several years, a number of studies have been published demonstrating the feasibility, acceptability, and adherence enhancing impact of medication adherence monitoring technologies on TB medication adherence in high-burden regions.  However, none of these studies have evaluated health outcomes as a primary endpoint.

Bruce Thomas, Arcady Founder, is a contributing author for recently published design manuscript outlining in detail the research protocol for such a health outcomes-oriented study.   The cluster randomised controlled trial, currently well underway in China, aims to evaluate the impact of a medication monitor-based treatment strategy for drug-sensitive TB patients on a composite poor outcome measured over 18 months from start of TB treatment. Composite poor outcome is being defined as either of poor outcome at the end of treatment (death, treatment failure, or loss to follow-up) or subsequent recurrence (culture positive for TB at 12 or 18 months or re-starting TB treatment in the follow-up period).  An economic evaluation will also be conducted as part of this study.

The trial will address an important gap in the current evidence base regarding adherence technologies generally and their use in TB patient management more specifically. It is hoped that the publication of this protocol and discussion thereof will assist and inform other studies currently being planned in a wide range of high burden regions.

View the publication of the design manuscript

Share this:

  • LinkedIn
  • Twitter
  • Facebook
  • Print

Filed Under: News

The Arcady Group

To turn the science of patient medication adherence into action

Resource Formats

  • Scientific Literature
  • Technology Toolkits
  • Conference Presentation
  • Special Report
  • How-to Guides
  • News/Press Release
  • Video
  • Infographic

Insights

  • Announcements
  • Insights
  • Links to Noteworthy
  • Materials Presented
  • Presentations

About Us

  • Our Vision
  • About Our Company
  • How we work
  • About Our Founder
  • Our Core Team
  • Code of Ethics

Illustrative Engagements

  • Illustrative Engagements
  • Medicines for All Institute Initiative
  • Patient Adherence
  • TB Adherence Supply Chain
  • TB Adherence Survey

© Copyright 2019 The Arcady Group · All Rights Reserved · Website Design by Richmond Digital Marketing